The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Congenital Heart Disease Occluder Device Market Research Report 2024
Synopsis
CHD occluders are medical devices intended for the closure of the remnant opening, or a defect, in the heart resulting from congenital abnormal development.
Global Congenital Heart Disease Occluder Device market is projected to reach US$ 374.4 million in 2029, increasing from US$ 243 million in 2022, with the CAGR of 6.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Congenital Heart Disease Occluder Device market research.
The coronary heart disease occluder market is driven by the increasing prevalence of coronary heart disease (CHD) and the demand for minimally invasive treatment options. CHD is a leading cause of morbidity and mortality worldwide, leading to the need for effective and safe treatment devices. Coronary heart disease occluders are specialized devices used in percutaneous procedures to close or occlude abnormal openings in the heart, such as septal defects or patent foramen ovale. These occluders offer advantages over traditional surgical methods, such as reduced procedural risks, shorter hospital stays, and quicker recovery times. Moreover, advancements in medical technology and imaging techniques have improved the accuracy and success rates of these procedures, contributing to market growth. However, the market also faces challenges, including the high cost of occluder devices and the need for specialized training for healthcare professionals performing these procedures. Additionally, the stringent regulatory approval process for medical devices poses obstacles to new market entrants. To succeed, manufacturers need to focus on cost-effectiveness, continuous innovation, and collaboration with healthcare providers to improve patient outcomes and expand their presence in the coronary heart disease occluder market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Congenital Heart Disease Occluder Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Segment by Type
ASD Occluder
VSD Occluder
PDA Occluder
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Congenital Heart Disease Occluder Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
CHD occluders are medical devices intended for the closure of the remnant opening, or a defect, in the heart resulting from congenital abnormal development.
Global Congenital Heart Disease Occluder Device market is projected to reach US$ 374.4 million in 2029, increasing from US$ 243 million in 2022, with the CAGR of 6.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Congenital Heart Disease Occluder Device market research.
The coronary heart disease occluder market is driven by the increasing prevalence of coronary heart disease (CHD) and the demand for minimally invasive treatment options. CHD is a leading cause of morbidity and mortality worldwide, leading to the need for effective and safe treatment devices. Coronary heart disease occluders are specialized devices used in percutaneous procedures to close or occlude abnormal openings in the heart, such as septal defects or patent foramen ovale. These occluders offer advantages over traditional surgical methods, such as reduced procedural risks, shorter hospital stays, and quicker recovery times. Moreover, advancements in medical technology and imaging techniques have improved the accuracy and success rates of these procedures, contributing to market growth. However, the market also faces challenges, including the high cost of occluder devices and the need for specialized training for healthcare professionals performing these procedures. Additionally, the stringent regulatory approval process for medical devices poses obstacles to new market entrants. To succeed, manufacturers need to focus on cost-effectiveness, continuous innovation, and collaboration with healthcare providers to improve patient outcomes and expand their presence in the coronary heart disease occluder market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Congenital Heart Disease Occluder Device market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore & Associates
Starway
Coherex Medical
Cardia
MicroPort
Segment by Type
ASD Occluder
VSD Occluder
PDA Occluder
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Congenital Heart Disease Occluder Device report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Congenital Heart Disease Occluder Device Market Overview
1.1 Product Overview and Scope of Congenital Heart Disease Occluder Device
1.2 Congenital Heart Disease Occluder Device Segment by Type
1.2.1 Global Congenital Heart Disease Occluder Device Market Value Comparison by Type (2023-2029)
1.2.2 ASD Occluder
1.2.3 VSD Occluder
1.2.4 PDA Occluder
1.3 Congenital Heart Disease Occluder Device Segment by Application
1.3.1 Global Congenital Heart Disease Occluder Device Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Congenital Heart Disease Occluder Device Market Size Estimates and Forecasts
1.4.1 Global Congenital Heart Disease Occluder Device Revenue 2018-2029
1.4.2 Global Congenital Heart Disease Occluder Device Sales 2018-2029
1.4.3 Global Congenital Heart Disease Occluder Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Congenital Heart Disease Occluder Device Market Competition by Manufacturers
2.1 Global Congenital Heart Disease Occluder Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Congenital Heart Disease Occluder Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Congenital Heart Disease Occluder Device Average Price by Manufacturers (2018-2023)
2.4 Global Congenital Heart Disease Occluder Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Congenital Heart Disease Occluder Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Congenital Heart Disease Occluder Device, Product Type & Application
2.7 Congenital Heart Disease Occluder Device Market Competitive Situation and Trends
2.7.1 Congenital Heart Disease Occluder Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Congenital Heart Disease Occluder Device Players Market Share by Revenue
2.7.3 Global Congenital Heart Disease Occluder Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Congenital Heart Disease Occluder Device Retrospective Market Scenario by Region
3.1 Global Congenital Heart Disease Occluder Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Congenital Heart Disease Occluder Device Global Congenital Heart Disease Occluder Device Sales by Region: 2018-2029
3.2.1 Global Congenital Heart Disease Occluder Device Sales by Region: 2018-2023
3.2.2 Global Congenital Heart Disease Occluder Device Sales by Region: 2024-2029
3.3 Global Congenital Heart Disease Occluder Device Global Congenital Heart Disease Occluder Device Revenue by Region: 2018-2029
3.3.1 Global Congenital Heart Disease Occluder Device Revenue by Region: 2018-2023
3.3.2 Global Congenital Heart Disease Occluder Device Revenue by Region: 2024-2029
3.4 North America Congenital Heart Disease Occluder Device Market Facts & Figures by Country
3.4.1 North America Congenital Heart Disease Occluder Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Congenital Heart Disease Occluder Device Sales by Country (2018-2029)
3.4.3 North America Congenital Heart Disease Occluder Device Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Congenital Heart Disease Occluder Device Market Facts & Figures by Country
3.5.1 Europe Congenital Heart Disease Occluder Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Congenital Heart Disease Occluder Device Sales by Country (2018-2029)
3.5.3 Europe Congenital Heart Disease Occluder Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Congenital Heart Disease Occluder Device Market Facts & Figures by Country
3.6.1 Asia Pacific Congenital Heart Disease Occluder Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Congenital Heart Disease Occluder Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Congenital Heart Disease Occluder Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Congenital Heart Disease Occluder Device Market Facts & Figures by Country
3.7.1 Latin America Congenital Heart Disease Occluder Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Congenital Heart Disease Occluder Device Sales by Country (2018-2029)
3.7.3 Latin America Congenital Heart Disease Occluder Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Congenital Heart Disease Occluder Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Congenital Heart Disease Occluder Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Congenital Heart Disease Occluder Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Congenital Heart Disease Occluder Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Congenital Heart Disease Occluder Device Sales by Type (2018-2029)
4.1.1 Global Congenital Heart Disease Occluder Device Sales by Type (2018-2023)
4.1.2 Global Congenital Heart Disease Occluder Device Sales by Type (2024-2029)
4.1.3 Global Congenital Heart Disease Occluder Device Sales Market Share by Type (2018-2029)
4.2 Global Congenital Heart Disease Occluder Device Revenue by Type (2018-2029)
4.2.1 Global Congenital Heart Disease Occluder Device Revenue by Type (2018-2023)
4.2.2 Global Congenital Heart Disease Occluder Device Revenue by Type (2024-2029)
4.2.3 Global Congenital Heart Disease Occluder Device Revenue Market Share by Type (2018-2029)
4.3 Global Congenital Heart Disease Occluder Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Congenital Heart Disease Occluder Device Sales by Application (2018-2029)
5.1.1 Global Congenital Heart Disease Occluder Device Sales by Application (2018-2023)
5.1.2 Global Congenital Heart Disease Occluder Device Sales by Application (2024-2029)
5.1.3 Global Congenital Heart Disease Occluder Device Sales Market Share by Application (2018-2029)
5.2 Global Congenital Heart Disease Occluder Device Revenue by Application (2018-2029)
5.2.1 Global Congenital Heart Disease Occluder Device Revenue by Application (2018-2023)
5.2.2 Global Congenital Heart Disease Occluder Device Revenue by Application (2024-2029)
5.2.3 Global Congenital Heart Disease Occluder Device Revenue Market Share by Application (2018-2029)
5.3 Global Congenital Heart Disease Occluder Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Congenital Heart Disease Occluder Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Congenital Heart Disease Occluder Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Boston Scientific
6.2.1 Boston Scientific Corporation Information
6.2.2 Boston Scientific Description and Business Overview
6.2.3 Boston Scientific Congenital Heart Disease Occluder Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Boston Scientific Congenital Heart Disease Occluder Device Product Portfolio
6.2.5 Boston Scientific Recent Developments/Updates
6.3 LifeTech
6.3.1 LifeTech Corporation Information
6.3.2 LifeTech Description and Business Overview
6.3.3 LifeTech Congenital Heart Disease Occluder Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 LifeTech Congenital Heart Disease Occluder Device Product Portfolio
6.3.5 LifeTech Recent Developments/Updates
6.4 Lepu Medical
6.4.1 Lepu Medical Corporation Information
6.4.2 Lepu Medical Description and Business Overview
6.4.3 Lepu Medical Congenital Heart Disease Occluder Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lepu Medical Congenital Heart Disease Occluder Device Product Portfolio
6.4.5 Lepu Medical Recent Developments/Updates
6.5 Occlutech
6.5.1 Occlutech Corporation Information
6.5.2 Occlutech Description and Business Overview
6.5.3 Occlutech Congenital Heart Disease Occluder Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Occlutech Congenital Heart Disease Occluder Device Product Portfolio
6.5.5 Occlutech Recent Developments/Updates
6.6 W. L. Gore & Associates
6.6.1 W. L. Gore & Associates Corporation Information
6.6.2 W. L. Gore & Associates Description and Business Overview
6.6.3 W. L. Gore & Associates Congenital Heart Disease Occluder Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 W. L. Gore & Associates Congenital Heart Disease Occluder Device Product Portfolio
6.6.5 W. L. Gore & Associates Recent Developments/Updates
6.7 Starway
6.6.1 Starway Corporation Information
6.6.2 Starway Description and Business Overview
6.6.3 Starway Congenital Heart Disease Occluder Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Starway Congenital Heart Disease Occluder Device Product Portfolio
6.7.5 Starway Recent Developments/Updates
6.8 Coherex Medical
6.8.1 Coherex Medical Corporation Information
6.8.2 Coherex Medical Description and Business Overview
6.8.3 Coherex Medical Congenital Heart Disease Occluder Device Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Coherex Medical Congenital Heart Disease Occluder Device Product Portfolio
6.8.5 Coherex Medical Recent Developments/Updates
6.9 Cardia
6.9.1 Cardia Corporation Information
6.9.2 Cardia Description and Business Overview
6.9.3 Cardia Congenital Heart Disease Occluder Device Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Cardia Congenital Heart Disease Occluder Device Product Portfolio
6.9.5 Cardia Recent Developments/Updates
6.10 MicroPort
6.10.1 MicroPort Corporation Information
6.10.2 MicroPort Description and Business Overview
6.10.3 MicroPort Congenital Heart Disease Occluder Device Sales, Revenue and Gross Margin (2018-2023)
6.10.4 MicroPort Congenital Heart Disease Occluder Device Product Portfolio
6.10.5 MicroPort Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Congenital Heart Disease Occluder Device Industry Chain Analysis
7.2 Congenital Heart Disease Occluder Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Congenital Heart Disease Occluder Device Production Mode & Process
7.4 Congenital Heart Disease Occluder Device Sales and Marketing
7.4.1 Congenital Heart Disease Occluder Device Sales Channels
7.4.2 Congenital Heart Disease Occluder Device Distributors
7.5 Congenital Heart Disease Occluder Device Customers
8 Congenital Heart Disease Occluder Device Market Dynamics
8.1 Congenital Heart Disease Occluder Device Industry Trends
8.2 Congenital Heart Disease Occluder Device Market Drivers
8.3 Congenital Heart Disease Occluder Device Market Challenges
8.4 Congenital Heart Disease Occluder Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
